S. 1702In committeeHealth care
Medicare, Medicaid would have to cover app-based prescription therapies
Data as of July 14, 2026
Starting in 2026, Medicare and Medicaid would be required to cover FDA-cleared prescription digital therapeutics like treatment apps.45-second read · 5 questions answered below
Decoded
What does this do?
This bill requires Medicare and Medicaid to cover "prescription digital therapeutics" — FDA-cleared software, apps, or devices that prevent, manage, or treat medical conditions primarily through software. Starting January 1, 2026, these products become a covered Medicare benefit, and Medicaid must cover them too. The bill also sets timelines for Medicare to create payment methods and billing codes for these products.
Who does it affect?
Medicare and Medicaid patients who could be prescribed app-based or software-based treatments, and manufacturers of these digital therapeutics. Doctors and health systems are also affected, since this creates a new billable treatment category.
Why does it matter?
This establishes a formal, government-reimbursed pathway for software-based treatments, changing how doctors can prescribe and bill for care alongside traditional drugs and devices.
What does it cost, and who pays?
- annual reporting required from manufacturers
- fines up to $10,000 per day for false reports
Where does it stand?
- Introduced
- Senate committee — You are here
- Senate vote
- House
- President's desk
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Access to Prescription Digital Therapeutics Act of 2025
- Introduced:
- May 8, 2025
- Latest action:
- May 8, 2025
Read twice and referred to the Committee on Finance.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.